OM Pharma is an international biopharmaceutical company specializing in the prevention of respiratory and urinary tract infections. As a committed local player, we train and support the talents of tomorrow through meaningful and educational internships.
In this context, we are offering a paid 4 to 6-month internship, ideally starting in September 2026 (or as agreed), based at our headquarters in Meyrin. Under the guidance of the Head of Business Development & Alliance Management and in close collaboration with the regional commercial, business insights and finance teams, your mission is to support the identification and assessment of business development opportunities for OM Pharma's brand portfolio worldwide.
Your main responsibilities are as follows:
To carry out these activities, we are looking for a person with the following profile:
This internship will enable you to:
You are an analytical, proactive and detail-oriented individual. After receiving initial guidance, you are able to work independently, take ownership of your tasks and drive them forward with rigor and efficiency. You enjoy working with data and presenting your findings in a clear and structured manner. With excellent interpersonal skills, you are comfortable interacting with multiple stakeholders in a multicultural environment and thrive in a collaborative setting.
If you are looking for an internship where you can develop your business acumen, analytical capabilities and strategic thinking while contributing to the growth of a pharmaceutical company with international ambitions, this opportunity is for you. We look forward to receiving your application and getting to know you!
IMPORTANT This internship is only open to students whose academic programme requires a mandatory internship as part of the degree curriculum Candidates must be able to provide a valid tripartite internship agreement, and the internship duration must meet the minimum requirements set by their educational institution.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
For more information, visit the website: ompharma.com

We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance.
Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates.
Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners.